Fanconi Canada
Learn more about:
Related Access Program
Gerard Vockley, MD, PhD – ACYL-CoA DEHYDROGENASE FAMILY, MEMBER 9, DEFICIENCY of
Children’s Hospital of Philadelphia – Bone Marrow Failure Syndrome
Korea University Guro Hospital – Myocardial Infarction
University of California, San Francisco – Bone Marrow Failure
University of Pittsburgh – ACYL-CoA DEHYDROGENASE FAMILY, MEMBER 9, DEFICIENCY of
Washington University School of Medicine – Erythrocytosis, Familial, 2
Novartis Pharmaceuticals – Heart Failure With Reduced Ejection Fraction (HF-rEF)
Baylor College of Medicine – Growth Failure
Baylor College of Medicine – Persistent Hyperinsulinemic Hypoglycemia of Infancy (PHHI)
Xiaofan Zhu – Fanconi Anemia
Eli Lilly and Company – Stimulator of Interferon Genes (STING)-Associated Vasculopathy With Onset During Infancy (SAVI)
Xiaofan Zhu – Fanconi Anemia
Fanconi Canada is a registered charity that funds research in Canada into an effective treatment and, ultimately, a cure for Fanconi anemia and serves as a support network for affected Canadian families.